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Abstract
Molecular microbiologists depend heavily on laboratory strains of bacteria, which are ubiquitous across the community of 
research groups working on a common organism. However, this presumes that strains present in different laboratories are 
in fact identical. Work on a culture of Vibrio cholerae preserved from 1916 provoked us to consider recent studies, which have 
used both classical genetics and next- generation sequencing to study the heterogeneity of laboratory strains. Here, we review 
and discuss mutations and phenotypic variation in supposedlyisogenic reference strains of V. cholerae and Escherichia coli, and 
we propose that by virtue of the dissemination of laboratory strains across the world, a large ‘community evolution’ experiment 
is currently ongoing.
Much of our current knowledge of bacteriology has been 
founded on the study of laboratory strains that are members 
of a species of interest. These strains are often deeply char-
acterized, have had their genomes sequenced to completion, 
and are present in laboratories around the world. Standard-
izing on a handful of laboratory strains for molecular studies, 
rather than using environmental or clinical isolates, enables 
reproducible studies of a single strain’s genetics and physiol-
ogy. This facilitates the stepwise accumulation of knowledge 
in research – as one group publishes on the physiology of a 
laboratory strain, another group can build upon that knowl-
edge when they study their own stock of that strain. A large 
caveat to focusing on limited numbers of lab strains is that 
just as type strains define bacterial species taxonomically [1], 
a type strain is not the archetype of a species [2]. Similarly, it 
can be argued that we know more about our laboratory strains 
of bacteria at a genetic and biochemical level than we do about 
a species as a whole [3].
In a recent study, we and our collaborators revived a lyophi-
lized stock of NCTC 30, a Vibrio cholerae first isolated in 
1916 [4]. We sequenced the genome of this isolate, as well as 
examining its morphology and phenotype. Although we did 
not find many previous studies that had examined NCTC 30 
[5–7] (Fig. 1), we took comfort in the fact that the cultures 
with which we worked behaved similarly to the findings 
reported in previous papers. We observed that NCTC 30 was 
phylogenetically distinct from pandemic V. cholerae, in agree-
ment with a previous taxonomic study [6]. Concordant with 
another study, we found that NCTC 30 was less susceptible 
to ampicillin than NCTC 5395, another V. cholerae [7], and 
we identified a functional β-lactamase gene in the genome 
of NCTC 30 that we believe confers this phenotype [4]. All 
of this reassured us that although we were working with a 
bacterial stock that has been maintained for over 102 years, 
we were likely to be handling a descendent or close relative 
of the cultures studied in the past.
However, a striking difference between our results and 
previous reports was the finding that our stock of NCTC 30 
did not express flagella when examined microscopically, and 
was not motile on soft agar plates [4]. This disagreed with 
a previous report, which had described NCTC 30 as being 
flagellated [7]. Moreover, we were able to identify a mutation 
in our NCTC 30 genome, which we believe is responsible for 
this phenotype. Since it is wholly possible that spontaneous 
mutation due to long- term culture led to the loss of flagella 
in NCTC 30, we confirmed that this mutation is present in 
the batches of NCTC 30 currently available to purchase from 
Public Health England Culture Collections. Thus, researchers 
that now choose to study NCTC 30 ought to be working with 
a culture with the same genotype and phenotypes as our stock.
Discrepancies between what one ‘expects’ of a laboratory 
strain and how it actually behaves in vitro are a fascinating, 
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and yet potentially problematic, aspect of bacteriology. Our 
study of NCTC 30 meant that we felt it timely to consider the 
variability of laboratory strains between and within laborato-
ries, and the potentially fascinating community evolution that 
has been ongoing across these laboratories. Below, we address 
some recent examples of discrepancies between supposedly 
isogenic stocks of laboratory strains of bacteria, and between 
those strains and their reference genome sequence.
V. cholerae researchers typically make use of a small number of 
reference laboratory strains, which have been shared amongst 
laboratories worldwide and are used for genetic experiments, 
phenotypic comparisons between V. cholerae biotypes, etc. 
The initial V. cholerae reference genome sequence was deter-
mined in 2000 by Heidelberg and colleagues by sequencing 
the serogroup O1 biotype El Tor strain N16961 [8]. However, 
differences between a published genome sequence for a labo-
ratory strain and the actual genome of the organism held in a 
laboratory stock can confound research findings. For instance, 
Val et al. used N16961 as a reference strain for studying the 
timing of V. cholerae chromosomal replication, but found 
discrepancies between the N16961 reference sequence and 
their results [9]. In their data, they identified an inversion 
flanked by rRNA operons in the genome of their N16961 stock 
relative to that of the reference sequence [9]. They confirmed 
that the chromosomal orientation in their N16961 cultures 
was common to N16961 stocks kept by other laboratories, 
as well as in other V. cholerae [9], and speculated that the 
inversion had occurred in the original stock of N16961 that 
was sequenced by Heidelberg et al. [8, 9].
Similar differences between published reference sequences 
and the genomes of laboratory strains have been identified in 
the case of the V. cholerae A1552 reference strain, the genome 
of which has been sequenced at least three times in the last 2 
years [10–12]. Kemter et al., in a study of Vibrio chromosomal 
replication termination, used the N16961 reference sequence 
to design custom microarrays for this work, but found several 
inversions between their A1552 strain’s sequence and the 
reference N16961 genome [11]. The isolate sequenced by 
Kemter et al. contained an inversion characteristic of A1552, 
which was validated using long- read sequencing [11]. The 
genome sequence was published alongside the paper, and 
the sequenced strain was deposited in the DSMZ culture 
collection. Just as we have discussed for NCTC 30, purchase 
of A1552 from DSMZ ought to provide a researcher with the 
same bacteria as those characterized previously [11].
Discrepancies between expected and observed phenotypes 
can also confound genetic experiments in laboratory 
strains. An example of this was published in 2016, in 
which seven laboratory stocks of the V. cholerae reference 
strain C6706 were compared for their ability to be naturally 
transformed [13]. The natural competence of V. cholerae 
can be exploited by researchers to mutagenise V. cholerae 
experimentally [14–16]. Natural competence is induced in 
V. cholerae in response to being grown on chitin [14], and 
is also regulated by quorum sensing [17–19]. The master 
regulator of quorum sensing in V. cholerae, HapR, positively 
regulates genes, which encode components of the DNA- 
uptake apparatus, and negatively regulates expression of 
the dns nuclease gene [17, 20] (summarized in Fig. 2). It 
is well known in the V. cholerae community, for instance, 
that N16961 cannot be transformed naturally [14], due to 
a frameshift in the hapR gene [21, 22]. In the absence of 
HapR, dns is not repressed under conditions which would 
otherwise promote natural competence, leading to the 
degradation of exogenous DNA [20]. hapR mutations have 
been suggested to occur frequently in V. cholerae [22], and 
this has also been suggested to be as a consequence of the 
intrinsic bias towards collecting virulent isolates [15]; HapR 
downregulates the expression of cholera toxin and the toxin 
co- regulated pilus, principal V. cholerae virulence determi-
nants (Fig. 2), and thus an isolate lacking functional hapR 
might cause a more acute disease, leading to hospitalization 
Fig. 1. Overview of the curation of NCTC 30. NCTC 30 was isolated in 1916, transferred to the Lister Institute, and subsequently 
transferred into the NCTC collection in 1920. The strain was lyophilized in 1950 and four consecutive lyophilized stock batches have 
been prepared since then. Assorted manuscripts have studied NCTC 30 since its isolation, including [4–7]. Figure drawn using records 
in the supplementary data of [4].
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and the isolation of V. cholerae more likely to be added to 
a strain collection [15].
Various researchers reported that they were unable to effect 
natural transformation in C6706, leading to Stutzmann and 
Blokesch’s study [13]. They found that the seven C6706 stocks 
examined had wild- type hapR alleles, but four contained a 
mutant luxO allele predicted to encode a mutant LuxOG333S 
protein [13]. This correlated with impaired quorum sensing- 
dependent phenotypes, such as chitin- induced transforma-
tion and reduced type VI secretion system- mediated killing 
of E. coli prey bacteria, as well as reduced levels of hapR 
transcription and a concomitant change in the expression of 
the HapR regulon [13]. They concluded that the circulation 
of quorum sensing- deficient strains of C6706 necessitated 
that researchers working with this strain should confirm the 
luxO genotype of their laboratory stocks, if discordant natural 
transformation phenotypes manifest. They suggested that the 
presence of the same luxO allele in these four stocks meant 
that the same luxO mutant strain had been passed amongst 
four laboratories [13].
It has been shown that prolonged maintenance of toxigenic V. 
cholerae on agar stabs can select for spontaneous nontoxigenic 
mutants, which arise due to mutation in the toxR promoter 
[23]. These toxR mutants do not express the ToxR regulon, 
including the cholera toxin, and gain a competitive growth 
advantage over toxigenic cells in vitro [23] (Fig. 2). Likewise, 
luxO* mutations producing constitutively active LuxO have 
been reported to arise in Vibrio fischeri cultures that are 
maintained in stationary phase for prolonged periods of time 
[24]. These luxO* mutants gained a fitness advantage over 
wild- type V. fischeri under the conditions used in the study 
[24]. The mutant LuxOG333S protein found in C6706 stocks has 
been shown to mimic constitutively active LuxO [25] (Fig. 2). 
It is plausible that C6706 luxO* mutants possess a competitive 
advantage over their wild- type counterparts, leading to the 
isolation of such mutants during continuous passage and their 
subsequent dissemination to laboratories worldwide. It is also 
possible that these luxO* mutants express elevated levels of 
virulence determinants compared to the wild- type C6706 
(Fig. 2). Mutations affecting the interactions between LuxO, 
HapR and AphA directly modulate virulence and cholera 
toxin expression in V. cholerae [26] (Fig. 2), and since C6706 
is a lab strain commonly used for studying the regulation of 
V. cholerae virulence, mutants may inadvertently have been 
selected by researchers that express greater, more detectable, 
levels of virulence determinants, potentially distorting our 
view of the evolutionary trajectory of natural isolates.
V. cholerae are not the only bacteria susceptible to lab- to- lab 
variation in supposedly isogenic strains. Numerous exam-
ples of the same phenomenon in E. coli have been reported. 
Although the prototype E. coli K-12 was first isolated in 
1922, from a convalescent diptheria patient in Palo Alto, CA, 
USA [27], its descendants continue to be used by researchers 
worldwide. In 2006, Hayashi et al. [28] reported genome 
Fig. 2. Laboratory strains of bacteria harbour mutations in several pathways which converge on increasing fitness in vitro. Phosphorylated 
LuxO (LuxO~P) decreases in concentration in V. cholerae cells as the population of bacteria grows, measured by quorum sensing. LuxO~P 
represses HapR; thus, at high- cell density, HapR abundance increases as the concentration of active LuxO~P decreases. HapR influences 
quorum- dependent phenotypes such as natural competence and virulence, the latter by repressing aphA, an activator of virulence 
gene expression in V. cholerae [26]. Mutations in hapR and luxO therefore influence these phenotypes. Other mutations can prevent 
the activation of the virulence regulon, such as in toxR, or producing constitutively activated LuxO* mimicking low- cell density quorum 
sensing, thereby forcing the maintenance of HapR repression of the virulence regulon. Similarly, mutations in rpoS are reported to 
repress virulence, and therefore increase the fitness in vitro of these mutants relative to wild- type cells.
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sequences for two such laboratory strains, MG1655 and 
W3110, in a manuscript which accompanied the announce-
ment of the Keio mutant collection [29]. The Keio mutants 
were constructed in BW25113 [30], a strain of E. coli derived 
from W1485, a common ancestor both of MG1655 [27, 31] 
and W3110 [27, 32]. The pedigree for BW25113 was reported 
in great detail upon publication of the Keio collection [29], 
and its genome sequence was subsequently determined 
[33]. Although an in- depth review of E. coli strain pedigrees 
is beyond the scope of this article, it would be remiss not 
to mention the work of organizations such as the E. coli 
Genetic Stock Center (CGSC) and Barbara Bachmann, its 
former curator, in maintaining extensive records of strain 
provenance, genetic description and pedigree [27, 32, 34]. 
Hayashi et al. reported heterogeneity amongst stocks of 
W3110 from laboratories across Japan, which they linked 
chiefly to IS element transposition events, which may have 
occurred during storage in stabs [28] – it is accepted that 
genome mutation takes place while E. coli is maintained as a 
stab culture [35]. They speculated that the limited variation 
that they observed between W3110 and MG1655, despite 
the two strains having been separated from one another 
over 50 years prior to their publication, might have been a 
consequence of using lyophilization as a storage method for 
these strains [28, 36].
Similarly, a recent study by Desroches et al. investigated the 
provenance and evolution of NCTC 86, the Escherich type 
strain of E. coli [37]. In this work, they sequenced cultures 
of NCTC 86 from stocks at NCTC, the ATCC, DSMZ and 
Centre de Ressources Biologiques de l’Institut Pasteur, as 
well as using two additional previously published sequences 
from NCTC stocks [38, 39] (a third sequence of this isolate 
was reported in [40] but not included in this analysis). The 
authors found striking heterogeneity in the genomes of these 
supposedly identical E. coli cultures, ranging from differences 
in plasmid replicon sequences being present in various stocks, 
to single- nucleotide polymorphisms and inactivating muta-
tions in mutation- prevention pathways [37]. The authors were 
able to correlate some of these differences to the records of 
how NCTC 86 was shared between these culture collections, 
and from where the sequenced isolates were obtained [37]. A 
similar study was performed in Campylobacter jejuni, where 
23 stocks of the laboratory strain NCTC 11168 from across 
the UK were both sequenced and phenotyped [41]. These C. 
jejuni stocks varied in their growth rates, motility, virulence, 
and the types and numbers of mutations in their genome, 
despite ostensibly being the same strain.
Just as certain pathways seem to be commonly mutated in V. 
cholerae laboratory strains (e.g. quorum- sensing pathways), 
there are mutations common to lab strains of other species. 
For instance, mutations in rpoS are found in the W3110 
and NCTC 86 strains discussed above [28, 37]. rpoS muta-
tions are known to occur during the process of laboratory 
adaptation [42, 43], or as a consequence of transferring 
bacterial strains between laboratories [44]. It is important 
to note, however, that the increased fitness of toxR mutant 
V. cholerae relative to wild- type cells is rpoS- independent 
[23]. Mutations in rpoS can confer a growth advantage to E. 
coli in a laboratory (e.g. grown at 37 ̊ C in Luria–Bertani or 
minimal media) [45], and contribute to virulence attenua-
tion associated with laboratory strains, such as in the LT2 
strain of Salmonella enterica serovar Typhimurium [46] 
(Fig. 2). The gain of fitness conferred by these laboratory- 
acquired mutations confers a fitness advantage on these 
mutants relative to the wild- type, and appears to be a theme 
common to the discussion above. Whether mutations are 
acquired in quorum sensing [24], virulence regulons [23] 
or in rpoS [42–44], there appears to be a convergence on 
laboratory culture environments selecting for mutants 
that have a selective fitness advantage over the wild- type 
(Fig. 2), just as occurs in in vitro artificial evolution experi-
ments [47, 48].
The discussion above illustrates the fact that phenotypic 
differences between laboratories’ strains offer an interesting 
opportunity to dissect the scientific basis underpinning 
those differences. This necessitates that researchers are 
willing to share their isolates with one another, or that they 
deposit important isolates in culture collections. The use 
of appropriate preservation and meticulous record cura-
tion means that a fellow researcher who orders a bacterial 
stock reported in a paper, from a culture collection, can 
be more confident that the organism they receive is that 
which produced the phenotypes in a previous publication 
[49]. Moreover, as the genome sequences of strain collec-
tions become freely available, the research community will 
benefit from the availability of biological and bioinformatic 
resources in which high levels of confidence can be had.
Simply by virtue of disseminating strains to different 
laboratories, researchers may have unwittingly conducted 
a natural evolution experiment. Comparing lab strains 
across different groups could present interesting opportu-
nities to study evolution, or to resolve differences that are 
observed, such as explaining the presence of C6706 luxO 
mutants in laboratories’ strain collections. A fascinating 
exercise, for instance, might be to attempt to retrieve stocks 
of NCTC 30 from laboratories worldwide, which might 
contain their own stocks, and to perform a comparison 
both phenotypically and genomically of these stocks. If 
data on the provenance of each isolate was available and 
could be used to construct a pedigree of how and when 
NCTC 30 was disseminated to each laboratory, this could 
be compared to the phylogenetics of the isolate. This 
might allow for identifying when phenotypes changed 
and mutations were accumulated over the course of the 
strain’s propagation. Although V. cholerae NCTC 30 has 
inspired this example, and we have discussed Vibrio 
cholerae and Escherichia coli predominantly in this paper, 
precisely the same ‘community evolution’ experiment is 
likely to be ongoing in laboratories worldwide. Bachmann 
[27] lamented in 1996 that ‘the derivation of many strains 
being isolated today can never be traced because of the 
failure of some laboratories to maintain adequate records 
of strain constructions’. Now, with the ever- decreasing cost 
of bacterial genome sequencing, phylogenetic analysis of 
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sequenced isolates with even partial records of their prov-
enance may enable the recapitulation of pedigrees, and 
in the absence of records of strain exchange but with the 
genome sequences of the strains, perhaps to work out ‘who 
gave what to who’ using a phylogeny, just as in studies of 
bacterial transmission (e.g. [50]).
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